Chu, M. B., Fesler, M. J., Armbrecht, E. S., Fosko, S. W., Hsueh, E., & Richart, J. M. (2013). High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases. Hindawi Publishing Corporation.

Chu, Melinda B., Mark J. Fesler, Eric S. Armbrecht, Scott W. Fosko, Eddy Hsueh, and John M. Richart. High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients With Melanoma Brain Metastases. Hindawi Publishing Corporation, 2013.

Chu, Melinda B., et al. High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients With Melanoma Brain Metastases. Hindawi Publishing Corporation, 2013.